Foreign AMT-130 gene therapy slows Huntington’s disease progression by seventy five percent A recent clinical trial has revealed that a new gene therapy called AMT-130 by uniQure can significantly slow the progression of Huntington’s disease by about seventy five percent over three Ugonna Nduka3 weeks ago3 weeks agoKeep Reading
